Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals received USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3%/0.1%. The approved generic drug addresses a market estimated at $110 million for twe